Maximus Schedules Fiscal 2024 Third Quarter Conference Call
Get Alerts MMS Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.2%
Revenue Growth %: -1.5%
Join SI Premium – FREE
TYSONS, Va.--(BUSINESS WIRE)-- Maximus (NYSE: MMS), a leading provider of government services worldwide, will issue a press release with its financial results for the three and nine months ended June 30, 2024, after market close on Wednesday, August 7, and will host a conference call the following day at 9:00 a.m. ET on Thursday, August 8.
Shareholders are invited to submit questions for management’s consideration by emailing [email protected] up to one hour prior to the call.
The call is open to the public and available by webcast or by phone at:
877.407.8289 (Domestic) / +1.201.689.8341 (International)
For those unable to listen to the live call, a recording of the webcast will be available on investor.maximus.com.
About Maximus
As a leading strategic partner to governments across the globe, Maximus helps improve the delivery of public services amid complex technology, health, economic, environmental, and social challenges. With a deep understanding of program service delivery, acute insights that achieve operational excellence, and an extensive awareness of the needs of the people being served, our employees advance the critical missions of our partners. Maximus delivers innovative business process management, impactful consulting services, and technology solutions that provide improved outcomes for the public and higher levels of productivity and efficiency of government-sponsored programs. For more information, visit maximus.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240702307236/en/
Investor Relations
Jessica Batt
James Francis
[email protected]
Media & Public Relations
Eileen Rivera
[email protected]
Source: Maximus
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump discloses over $1.4 billion in crypto income in 2025 filing
- Access Advance and Alibaba Announce Alibaba's Expanded Participation in the VDP Pool
- Vertex Announces US FDA Approval for Expanded Use of CASGEVY® for the Treatment of People Ages 2 Years and Older With Sickle Cell Disease or Transfusion-Dependent Beta Thalassemia
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share